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Aim: To investigate the effect of enterosorption on the development of paraneoplastic syndrome in mice with Lewis lung carcinoma 
(LLC). Materials and Methods: The study was performed on male С57/ВL6 mice with transplanted LLC. As an enterosorbent, highly 
activated powder fraction of HSGD was administered per os daily at a dose of 0.625 g/kg for two weeks starting from the 7th day after 
tumor cell transplantation. Analysis of hemo- and myelograms, morphological alterations in vital organs, the activities of catalase 
and superoxide dismutase, biochemical analysis of blood and quantitative analysis of hydroperoxides, malonic dialdehyde, аdvanced 
oxidation protein products was carried out by standard methods after completing the course of enterosorption. Ligand loading of blood 
plasma proteins was estimated by the method of differential scanning microcalorimetry. Results: Administration of enterosorbent resulted 
in inhibition of LLC growth and in nearly 2-fold decrease of lung metastases number (p < 0.05). Activation of granulocytic line in the 
bone marrow with nearly 3-fold enhancement of mitotic activity took place after enterosorbent administration. Red cell lineage indices 
and bone marrow cellularity remained unaltered. After enterosorption session, the studied biochemical indices of peripheral blood 
evidenced on decreasing the endogenous intoxication and oxidative stress levels, improving the functional state of kidneys, increasing 
the resistance of erythrocyte membranes and lowering the ligand loading of blood plasma transport proteins. Morphological structure 
of kidneys and liver confirmed significant positive effect of enterosorption. The data of morphologic examination of gastric fundus, 
small intestine, and large bowel slides after 2-week administration of enterosorbent showed its high safety and proper evacuation 
from intestine. Conclusion: The two-week long enterosorption session in mice with LLC caused the suppression of tumor growth and 
metastasis, normalization of bone marrow hemopoiesis. Enterosorption exerted a positive influence on the structural-morphologic 
indexes and regenerative potential of kidneys and liver, mitigated manifestations of oxidative stress, decreased the level of endogenous 
intoxication, promoted deliganding of albumin molecule and deloading of erythrocyte membranes.
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The motivation to use the method of enterosorption 
for treatment of mice with Lewis lung carcinoma (LLC) 
was based on multiple positive results of per os usage 
of carbon adsorbents for therapy of a number of pa-
thologies including acute radiation sickness, chronic 
glomerulonephritis, biliary and portal cirrhosis, severe 
forms of leptospirosis, food allergy, psoriasis, acute 
enteric infections, idiopathic dilation cardiomyopathy, 
and chronic renal failure [1–9], as well as severe my-
elo-, nephro-, cardio- and gonadotoxic side effects 
of intense cancer chemotherapy [10, 11].
All these reports evidenced on significant positive 
therapeutic pathomorphosis of mentioned patholo-
gies under the influence of enterosorption, first of all, 
on acceleration of reparative processes in damaged 
organs and tissues.
High regenerative potential of carbon enterosorbents 
demonstrates itself in pathologies of different etiology 
and points on an existence of some common elements 
in pathogenesis of these diseases which include, for 
example, the development of endogenous intoxica-
tion (EGI), oxidative stress, anemia, impaired excretory 
organs.
Malignant tumors exert systemic influence 
on an organism and therefore could cause the develop-
ment of paraneoplastic syndrome (PNS) which could 
be represented by certain immune conflict between 
tumor and organism, complex changes of structure and 
function of some organs, the development of significant 
metabolic disorders. According to the newest data, a sig-
nificant role in promotion of PNS manifestations belongs 
to proangiogenic factors produced at high level by ma-
lignant cells in vitro and in vivo [12]. Anemia is among 
the most crucial disorders caused by systemic influence 
of malignant tumor growth. By statistical data, anemia 
develops in nearly 30% of primary cancer patients [13], 
in 71% of patients with lung carcinoma (this cancer type 
is characterized by the highest rate of PNS development 
among all cancer types) [14], and in up to 90% of patients 
treated with chemotherapy [15]. Also, it has been shown 
that the risk of lethal outcome in the patients with anemia 
is by 65% higher than in the patients without anemia [16].
Submitted: July 19, 2017. 
*Correspondence:  E-mail: vsnikavera@gmail.com 
Abbreviations used: AlkP — alkaline phosphatase; ALT — alanine trans-
aminase; AOD — antioxidant defense; АОРР — аdvanced oxidation 
protein products; AST — aspartate transaminase; EGI — endogenous 
intoxication; GIT — gastrointestinal tract; G-SH — glutathione; HP — hy-
droperoxide; HSA — human serum albumin; LHP — lipid hydroperoxide; 
IMA — ischemia modified albumin; LLC — Lewis lung carcinoma; MDA — 
malonic dialdehyde; MMWS — middle molecular weight substances; 
PNS — paraneoplastic syndrome; SOD — superoxide dismutase.
Exp Oncol 2018
40, 1, 33–41
34 Experimental Oncology 40, 33–41, 2018 (March)
Severe EGI often observed in cancer patients could 
be caused by the products of tumor metabolism and 
biochemical disorders caused by the growth and 
mechanical action of the tumor [17]. Important role 
in the formation of EGI syndrome plays the dysfunc-
tion of natural mechanisms of detoxification [18]. 
Imbalance of metabolic processes at the background 
of decreased detoxification potential of an organism 
leads to “metabolic EGI” [19].
Presently it is accepted that EGI development 
could be significantly affected by oxidative stress via 
activation of free radicals and imbalanced rate of gen-
eration of compounds with antioxidant or prooxidant 
properties [20]. Prooxidants may serve as the media-
tors of inflammation, induce severe defects in activity 
of defensive antioxidant systems and their cofactors, 
and also exert negative influence on the state of dif-
ferent biologic compounds, including signaling mole-
cules. An excessive generation of free radicals could 
be responsible for the development of hyperviscosity, 
hypercoagulation, dysfunction of endothelium and 
protein modification [21]. Free radicals could be in-
volved in neoangiogenesis through activation of pro-
duction of vascular growth factors in endothelial and 
mesothelial cells [22]. The damaging action of free 
radicals is directed on three types of targets: lipids, 
nucleic acids, and proteins. An action of reactive oxy-
gen species could result in oxidation of amino acid 
residues and disturbed structure and function of the 
proteins. Hydroxyl radicals attacking protein molecules 
do not remain in free state but create the complexes 
with the proteins, which in turn become damaged and 
degraded by proteolytic enzymes [23]. For example, 
in the presence of hydroxyl radicals β2-microglobulin 
becomes fragmented or polymerized that is evidenced 
by the methods of fluorometry and circular dichroism, 
demonstrating the disappearance of the fraction with 
molecular weight of 12 kDa typical for β2-microglobulin 
and appearance of a band of high molecular weight 
cross-linked proteins [24]. The large part of oxidized 
proteins are functionally inactive and more accessible 
for proteolysis, are capable to accumulate in different 
tissues, mediate oxidative damage of DNA, may serve 
as a source of free radicals and reduce the sources 
of cell antioxidants such as ascorbic acid and gluta-
thione [25]. So, oxidized proteins could be not only 
“bystanders”, but also the active participants of the 
process of free radical damage occurring in a body 
at different pathologic states.
The central place among transport proteins of blood 
is occupied by human serum albumin (HSA) which 
is presented in blood plasma at a concentration of 45–
50 mg/ml. As far as plasma volume yields at average 
three liters, liver synthesized nearly 3 g of this protein 
per day; its half-life is 19–20 days. Functions of albumin 
include the regulation of osmotic pressure and trans-
port of many compounds of different chemical nature, 
including fatty acids, bile pigments, metabolites and 
toxins, medicinal preparations and poisons, and also 
ions of some metals such as copper, cobalt, aluminum, 
zinc, etc. [26]. While the major part of plasma copper 
is bound with ceruloplasmin, a natural antioxidant, 
HSA also possesses a tropism to ions of this metal, 
therefore some quantity of copper ions are in a complex 
with its molecule. At present time, there are multiple 
evidences on antioxidant activity of albumin [27]. This 
protein is capable to suppress generation of hydroxyl 
free radicals in the systems which contain copper ions 
and Н2О2. While attacking, hydroxyl radicals disturb 
the molecular structure of albumin, however, they are 
caught by it and tightly retained in a safe bound state. 
In turn, the damaged albumin undergoes degradation 
by proteolytic enzymes, and its loss is quickly compen-
sated by a newly synthesized portion of the protein. 
Potential targets for oxidants are sulfhydryl groups 
of the proteins, and in relation to albumin, an oxidation 
process utilizes its single free SH-group at Cys 34, with 
generation of sulfenic group [28].
An accumulation of toxic metabolites in a can-
cer patient’s organism is promoted by dysfunction 
of natural excretory-evacuation systems [29, 30], 
as well as decreased activity of a number of enzymatic 
complexes responsible for neutralization of exo- or en-
dotoxins [31]. Apart from this, in cancer patients there 
is observed the ligand overloading of cellular and 
humoral transport agents of blood and related mal-
function of toxic metabolite transfer [32]. High level 
of EGI observed in cancer patients as well as powerful 
pro-regenerative potential of carbon enterosorbents, 
indicate a necessity to study an effectiveness and 
rationale for their usage in adjuvant therapy of cancer 
patients.
This work presents an evidence for correcting ac-
tion of enterosorption toward hematologic indexes, 
morphologic and structural/functional parameters 
of natural excretory-evacuation and transport systems, 
including erythrocyte membranes and blood plasma 
serum albumin as well as some indexes of oxidative 
stress in mice with LLC.
MATERIALS AND METHODS
In the study, male С57/BL6 mice 2–2.5 months old 
weighting 18–23 g bred in the animal facility of Institute 
of Experimental Pathology, Oncology and Radiobio-
logy of the NAS of Ukraine (Kyiv, Ukraine) were used. 
The research was performed in accordance with the 
rules of local committee on ethic aspects of work with 
experimental animals. LLC was used as experimental 
tumor model [33].
Experimental animals were randomized by weight, 
and distributed in 4 groups (11 mice per group): 1) in-
tact animals; 2) mice with transplanted LLC (control 
group); 3) mice with transplanted LLC treated with en-
terosorbent (ES-group); 4) animals with transplanted 
LLC administered with water (through the probe) 
by the same schedule as ES-mice for an assessment 
of the effects of stress factors related to the placement 
of probe (SF-group).
Highly activated powder carbonic enterosorbent 
was prepared by grinding of microgranulated fraction 
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(diameter < 0.25 cm) of HSGD sorbent in multichannel 
grinding mill MCM-300 Н at separator rotation speed 
of 60 Hz.
Enterosorption has been performed daily for 
2 weeks. Powdered high-disperse fraction of the sor-
bent was resuspended in 0.5 ml of boiled water and 
administered orally through a probe, starting from 
day 7 after tumor cell transplantation. Total daily dose 
of enterosorbent was 0.625 g/kg body mass. Mice 
from SF-group were administered with 0.5 ml of boiled 
water.
To assess the effect of highly active powder carbon 
enterosorbent on gastrointestinal tract (GIT) mucosa, 
an additional group composed from 7 intact mice 
of the same weight was treated with enterosorbents 
at the same dosage and by analogous schedule.
Hemograms were analyzed by the method adapted 
for the study of blood cells of mice using the hemato-
logical analyzer “PCE 210” (ERMA, Japan).
The number and total volume of metastases in ex-
perimental animals were calculated using the method 
described earlier [34].
Bone marrow cells isolated from femoral bone 
of experimental animals were counted in hemocytome-
ter by the method [35]. To study the myelograms, the 
smears were prepared and stained by Pappenheim. 
For evaluation of cellular composition of bone mar-
row, an analysis was performed in total haemopoiesis 
pools dependent on cell differentiation grade, namely: 
myeloid lineage: immature granulocytic cells — myelo-
blasts, neutrophilic and eosinophilic promyelocytes, 
myelocytes, metamyelocytes; mature granulocytes — 
neutrophils and eosinophils banded or segmented; 
erythroid lineage: immature cells — erythroblasts, 
pronormocytes, basophilic normocytes, polychro-
matophilic or oxyphilic normocytes.
Mitotic activity was determined by the number 
of cells at the phase of mitosis (1000 cells of myelo-
gram per calculation).
Analysis of morphological structure of GIT, liver, and 
kidneys of mice was performed after enterosorption 
session was finished. Animals were immediately decapi-
tated, and biomaterials were fixed in 10% neutral forma-
lin, then paraffin embedded tissue blocks were routinely 
prepared. 5–6 µm slides were stained with hematoxylin 
and eosin and examined by light microscopy. Micropho-
tographs were done using System Microscope device 
with video camera Olympus BX 41 system, equipped 
with digital camera Camedia C-5050 zoom and Olympus 
DP 80 FT 3.2 software based on Pentium 4 computer 
with operation system Windows XP.
The quantity of generated hydroperoxides (HP) and 
malonic dialdehyde (MDA) were determined by the 
methods [36] and [37], respectively.
For quantitative evaluation of аdvanced oxidation 
protein products (АОРР) the method based on the 
reaction of interaction between potassium iodide, 
chloramine T and acetic acid was used. Optical density 
of reaction mixture was registered at the 340 nm wave 
length [38].
Concentration of ischemia modified albumin (IMA) 
was determined by the colorimetric method [39].
Concentrations of total protein, albumin, urea, uric 
acid, creatinine, alanine transaminase (ALT), aspartate 
transaminase (AST), alkaline phosphatase (AlkP) 
in blood were determined using test kits BioSystems. 
Osmotic resistance of erythrocytes was determined 
according to the method [40]. Complex-formation 
of albumin with vital dye methylene blue was assessed 
by the method [41].
The activities of catalase and superoxide dismutase 
(SOD) were determined by standard methods [42, 43].
To assess ligand loading of blood plasma proteins 
the method of differential scanning microcalorimetry 
was used. The blood plasma samples underwent 
thermal denaturation using apparatus DАСМ-4 (Push-
chino, Russia) at the heating rate of 1 °С/min.
Statistical analysis of the data has been performed 
using mathematical program for medico-biological 
statistics STATISTIСA 6.0. Variation-statistical pro-
cessing of the data was conducted using computer 
program Microsoft Excel 2007. For calculation and 
comparison of the reliability of the average values 
of the differences Student’s t-criterion was used; 
the differences with probability not less than 95% 
(р < 0.05) were considered significant.
RESULTS AND DISCUSSION
In our studies we used a previously created highly 
active carbon sorbent with spherical granulation 
HSGD-2 [44], which was grinded to get its powder 
form (average particle size is ≈ 2 µ). The fine carbon 
fraction is preferable because of a significantly larger 
external surface area compared to granules and, 
correspondingly, a higher sorption-kinetic potential, 
which was evaluated by adsorption of marker com-
pounds under standard conditions [45]. Moreover, 
highly dispersed aqueous suspensions of powder 
enterosorbents greatly facilitate the process of their 
oral administration to small animals and make it prac-
tically non-traumatic.
The indexes of adsorption of major marker com-
pounds by HSGD enterosorbent in the forms of spheri-
cal granules and powder are presented in Table 1.
It is necessary to note that observed differences 
between adsorption values of marker compounds 
depend not on those by absolute sorption capacity 
of the samples but on kinetic indexes predetermined 
by an availability of sorption pores which are higher 
in fine-disperse powder.
Table 1. Adsorption capacity of granulated and powdered HSGD-2 sorbent
Sample Methylene blue, mg/g
Creat-
inine, 
mg/g
В12, 
mg/g
Bilirubin, 
mg/g
Total pro-
tein, g/g
HSGD-2
γ = 0.155 g/cm3,
granules
664.26 140.64 444.08 15.67 1.23
HSGD-2
powder 963.16 161.57 1442.53 65.6 2.62
Despite high adsorption activity, powder entero-
sorbents were found to be absolutely non-aggressive 
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for GIT mucosa. The microphotographs demonstrate 
that after two-week long enterosorption session, the 
state of GIT of experimental animals is similar to that 
of intact mice. In histological structure of fundic gastric 
glands, villi and crypts of small intestine (duodenum), 
and large intestine mucosa (rectum) no pathologic 
alterations or abnormal inclusions were observed that 
evidenced on high safety and proper evacuation of the 
enterosorbents from an organism of experimental 
animals (Fig. 1).
The use of powder enterosorbent significantly 
influenced tumor growth dynamics in experimental ani-
mals. Starting from day 16 after tumor transplantation, 
in the group of animals treated with enterosorbents 
there has been registered a significant delay of tumor 
growth (Fig. 2) with the maximal antitumor effect at the 
22th day. Apart from this, 2-week session of powder en-
terosorbent therapy resulted in a significant metastasis 
suppression in mice with LLC, namely, nearly 2-fold 
decrease of metastases number in enterosorption 
Fig. 1. Microphotographs of the slides of gastric fundus (a), small intestine (duodenum) (b), and large bowel (rectum) (c) of mice 
(on the left — intact animals, on the right — intact animals after 2-week enterosorption (ES)). Hematoxylin-eosin, × 400
Experimental Oncology 40, 33–41, 2018 (March) 37
treated mice compared to the group of tumor growth 
control (p < 0.05) (Table 2).
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Fig. 2. Dynamics of tumor growth at the background of en-
terosorption
Table 2. The number and volume of metastases at day 22 after tumor 
transplantation
Group of animals Number of metastases Volume of metastases (mm3)
Control mice 10.3 ± 1.3 4.7 ± 2.3
Enterosorption 
treated mice 5.4 ± 1.5* 3.6 ± 0.6
Note: *The difference is significant compared to the control, p < 0.05.
An absence of stimulating effect of enterosorp-
tion on metastasis volume and primary tumor volume 
evidenced on the safety of sorbent use in auxiliary 
therapy of cancer patients.
The development of LLC was accompanied with 
reactive changes in bone marrow (Table 3). There has 
been registered an increase of proliferative acti vity 
of erythroid line cells up to 6.00 ± 1.15‰ (vs 1.5–3‰ 
at normal state) with simultaneous elevation of ery-
throid cells percent in myelogram. This effect could 
serve as a compensatory reaction of hemopoiesis 
toward anemia development in peripheral blood. After 
administration of physiologic solution (SF-group), the 
stress-related characteristic changes in bone marrow 
of the animals have been registered: nearly 2-fold 
increase of lymphocyte counts, decrease of mature 
granulocyte percent (due to their efflux in peripheral 
circulation) along with the trend for elevation of mitotic 
activity of granulocyte lineage cells.
In mice with LLC treated with enterosorbent, 
there was observed an activation of granulocytic 
lineage of hemopoiesis along with significant in-
crease of mitotic cell counts. The number of mitoses 
in erythroid lineage cells showed a trend for de-
crease while erythrocyte counts in peripheral blood 
increased. These data evidenced on an impairment 
of circulating erythrocytes (possibly of autoimmune 
genesis).
Regarding peripheral blood indexes of mice treated 
with powder eneterosorbents, the decrease of the 
fractions of lymphocytes and monocytes in leuko-
grams along with significant increase of the granu-
locyte fraction was observed. Hemoglobin content, 
and platelet and erythrocyte counts elevated by 23.3, 
54.5 and 30.0%, respectively. The results obtained 
were slightly different from these when microgranu-
lated carbon enterosorbent was used [44].
Table 3. Influence of enterosorption on bone marrow hemopoiesis in mice 
with LLC
Index, % Control group SF-group ES-group
Undifferentiated blasts 0 0 0.25 ± 0.25
Neutrophilic:
Myeloblasts, % 0.33 ± 0.17 1.67 ± 1.67 0.75 ± 0.25
Promyelocytes, % 4.33 ± 0.88 4.50 ± 0.50 3.12 ± 0.96
Myelocytes, % 11.33 ± 1.64 12.83 ± 0.72 10.75 ± 2.49
Metamyelocytes, % 10.50 ± 1.80 9.17 ± 1.64 11.62 ± 1.95
Banded neutrophiles, % 16.17 ± 5.64 10.33 ± 4.11 19.00 ± 2.48
Segmented neutro-
philes, % 10.83 ± 2.09 6.83 ± 3.61 14.12 ± 2.11
Eosinophilic:
Promyelocytes, % 0 0 0
Myelocytes, % 0.66 ± 0.44 0 0
Metamyelocytes, % 1.33 ± 1.67 0.83 ± 0.60 0.25 ± 0.25
Mature, % 1.83 ± 0.72 0.83 ± 0.16 0.88 ± 0.12
Immature granulo-
cytes, % 28.50 ± 1.26 27.5 ± 1.61 26.50 ± 3.09
Mature granulo-
cytes, % 28.83±8.14 18.0 ± 7.81 34.00 ± 3.67
Total granulocytes,% 57.33 ± 6.89 45.5 ± 8.41 60.50 ± 6.11
Erythroblasts, % 0.33 ± 0.17 0.17 ± 0.17 0.38 ± 0.24
Pronormocytes, % 1.00 ± 0.58 0.67 ± 0.67 0.62 ± 0.24
Normocytes:
Basophilic, % 8.83 ± 4.87 7.33 ± 2.49 3.62 ± 0.85
Polychromatophilic, % 12.50 ± 3.75 16.67 ± 5.08 14.12 ± 2.29
Oxyphilic, % 12.00 ± 4.07 9.67 ± 2.62 10.00 ± 2.34
Total erythroid cells, % 34.50 ± 7.80 34.5 ± 10.51 28.75 ± 0.50*
Myelo-erythroid  
ratio, RU 1.66 ± 0.69 1.45 ± 0.44 2.38 ± 0.50
Monocytes, % 0.50 ± 0.29 1.17 ± 0.93 0.25 ± 0.25
Lymphocytes, % 9.00 ± 1.32 18.17 ± 5.02 11.25 ± 1.93
Plasmocytes, % 0.12 ± 0.12 0 0
Reticular cells, % 0.12 ± 0.12 0 0.12 ± 0.12
Megacaryocytes, ‰ 0 0 0.25 ± 0.25
Mitotic index of red 
blood cell line, ‰ 6.00 ± 1.15 6.75 ± 2.06 3.00 ± 1.00
Mitotic index of white 
blood cell line, ‰ 2.00 ± 0.58 4.25 ± 1.40 13.00 ± 3.51*
Total mitotic index, ‰ 8.00 ± 1.53 11.00 ± 1.73 16.00 ± 4.04*
Note: *The difference is significant compared with group 1, p < 0.05.
Apart from increased erythrocyte counts, in pe-
ripheral blood of mice with LLC after enterosorption 
session we have revealed an increase of osmotic re-
sistance of erythrocyte membranes and partial resto-
ration of their acceptor function registered by binding 
with vital dye methylene blue (Fig. 3).
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Fig. 3. Indexes of osmotic resistance of erythrocytes (ORE) 
and their binding capacity by vital dye methylene blue in the 
groups of intact, control and enterosorption-treated mice. 
*p < 0.05 compared with control mice. RBC — red blood cells
Earlier it has been shown that despite an absence 
of systemic pharmacokinetics, enterosorbents could 
significantly decrease the toxic loading on kidney and 
liver. It is especially important in the situations if bar-
rier function of intestinal epithelium is weakened, 
while the presence of highly active enterosorbents 
in intestines serves as an artificial barrier against 
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the passage of an increased quantities of intestinal 
metabolic products, bacterial endotoxins and mi-
croflora, into the circulation [46–48]. As the result 
of such functional “time-out” in detoxification or-
gans, here are “launched” the natural regenerative 
processes [49–51], that finally lead to the decrease 
of endo genous detoxification degree [46, 52–54].
In LLC-bearing mice, in the morphology of kid-
neys and liver that are the organs not affected by me-
tastasis, there were observed multiple degenerative 
alterations, which were, possibly, caused by mani-
festations of PNS [55]. For example, on the slices 
of kidneys of animals from group 1 (tumor growth 
control) (Fig. 4, a, 1–2) one may see the tubules 
with evidence on a protein dystrophy of various 
degree, especially in convoluted tubules of cortex. 
In cytoplasm of nephrocytes of convoluted tubules 
there appeared hyaline-like protein globules and 
droplets that may merge with each other and fill all 
the cell. There were detected some tubules with 
necrobiosis — necrosis of separate epitheliocytes. 
Glomeruli were at the state of moderate atrophy 
of various degree. At the same time, there could 
be seen atrophic tubules of medulla with dramati-
cally flattened epithelium, which contain eosinophilic 
masses, lymphoid cells chambers.
After enterosorption (Fig. 4, b, 3–4) the functional 
state of kidneys became notably normalized. The 
structure of renal cortical cells was better preserved, 
compared to the control group. Cytoplasm of the 
majority of epitheliocytes was homogenous, more 
acidophilic, the lumen of the tubules was moderate, 
however, in some tubules one could observe insignifi-
cant destructive changes of epitheliocytes.
Along with positive morphologic alterations in the 
kidneys of animals under the influence of enterosor-
bents with potent regenerative potential, their function-
al activity was significantly improved: the concentration 
of uric acid and creatinine in blood plasma decreased 
notably, and urea content approached the values in the 
group of intact mice (Fig. 5). The content of “medium 
molecules” in blood plasma (integral index of EGI) 
decreased by 32.5%.
The indexes of liver function in enterosorbent-
treated animals did not go beyond the norm, too. 
Enterosorption caused significant decrease of ALT and 
AST activities (by 22.3 and 13.0%, respectively), total 
bilirubin content by 12.5%, AlkP by 5.4%, compared 
to the control group of tumor-bearing mice (Fig. 6).
After enterosorption session, the state of histo-
logic structure of liver parenchyma became signifi-
cantly improved: quite clear radially directed hepatic 
Fig. 4. Microphotographs of murine kidney sections: a — control mice; b — enterosorption-treated mice. Cortical (1, 3) and medul-
lary (2, 4) substances. Hematoxylin-eosin, × 400
Experimental Oncology 40, 33–41, 2018 (March) 39
trabeculae, moderately widened perisinusoidal spaces, 
hepatocytes of polygonal form, with clear round nuclei, 
nucleoli, and chromatine lumps were registered (Fig. 7). 
The observed elevated basophilism of the cytoplasm 
evidenced on the restoration of protein synthesis in liver. 
This was supported by an increased content of total 
protein and albumin by 16% and nearly 20% in the group 
of ES-mice compared to the control group.
Fig. 7. Microphotographs of liver sections of enterosorption-
treated mice. Hematoxylin-eosin, × 400
One should note that apart from the concentra-
tion index, the most important index is the content 
of “effective” protein fraction, i.e. the fraction with re-
stored transporting properties. However, in oncologic 
patients an oxidative modification of proteins which 
occurs upon the influence of reactive oxygen species 
often prevents normal functioning of the proteins. 
An intensity of this process is predetermined by amino 
acid composition of particular proteins and could 
be considered as an early marker of oxidative stress. 
Oxidative stress is accompanied with an increased 
level of the products of excessive lipid peroxidation, 
АОРР, suppression of endogenous antioxidant de-
fense (AOD) and, consequently, increased level of EGI.
The depletion of AOD reserves was reflected in the 
decreased activities of SOD and catalase in blood se-
rum by 69.0 and 34.5%, respectively, and decreased 
content of reduced glutathione (by 20.9%) compared 
to intact animals (Fig. 8, a). The characteristic reac-
tion of a body toward development of oxidative stress 
was an increased (compared to intact animals) blood 
serum levels of lipid hydroperoxide (LHP), MDA, АОРР, 
and IMA by 179, 61.54, 121.02 and 111.6%, respec-
tively (Fig. 8, b).
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Fig. 8. Indexes of AOD (a) and oxidant stress (b) in the 
groups of intact, control, and enterosorption-treated mice. 
*p < 0.05 compared with control mice
Enterosorption exerted an expressed positive ef-
fect on a pro-oxidant-antioxidant balance. So, the 
content of MDA, IMA, АОРР, and LHP in ES-group de-
creased by 53.85, 76.72, 152.79 and 149.0%, respec-
tively, compared to the control group of animals. Also, 
there was observed a significant activation of AOD: the 
activities of SOD and catalase, the major scavengers 
of free radicals and oxygen metabolites, and the main 
protectors of proteins, DNA, and cell membranes at the 
conditions of oxidative stress, increased by 35.0 and 
23.8%, respectively, while the level of reduced gluta-
thione increased by 30.9% (Fig. 8).
In recent years, the IMA index is considered 
as an oxidative stress marker along with the common 
indexes at different pathological states. Its increase 
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Fig. 5. The content of water-soluble uremic toxins and “median mol-
ecules” in the groups of intact, control, and enterosorption-treated 
mice. *p < 0.05 compared with control mice. MMWS — middle 
molecular weight substances
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Fig. 6. Indexes of cytolysis and cholestasis in the groups of in-
tact, control, and enterosorption-treated mice. *p < 0.05 com-
pared with control mice
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in the group of control mice with LLC compared to in-
tact animals (from 0.064 to 0.136 abs. u.) evidenced 
on disturbed structure of binding region of blood serum 
albumin in these animals and, consequently, on its de-
creased capability for cobalt binding. After administra-
tion of enterosorbent the decrease of this index to the 
value of 0.088 abs was observed, indicating a partial 
restoration of the structural-functional characteristics 
of albumin due to the decrease of its ligand loading. 
This hypothesis was supported in the study of ther-
modenaturation of blood serum of mice from control, 
ES-treated and intact groups. The corresponding 
melting curves of plasma samples are presented 
in Fig. 9. The main maximums of thermodenaturation 
endotherm belong to albumin fraction. The higher 
melting temperatures point on an increased ligand 
loading of albumin, while the shape of endotherms 
reflects the changes of its native conformation [56]. 
The melting temperature of blood plasma proteins 
of mice in ES-group decreased from 72 to 68 °С, along 
with some moderate positive changes in the shape 
of thermodenaturation curve.
Fig. 9. Original thermograms of blood plasma of mice: intact 
group (1), control group (2), and ES-treated group (3)
The results obtained by the method of DSC, 
demonstrate the noticeable deliganding the albumin 
molecule and partial normalization of its “morphology” 
after the enterosorption course.
In conclusion, the two-week long enterosorption 
session in mice with LLC caused the suppression 
of tumor growth and metastasis, weakening the mani-
festations of anemia and significant normalization 
of bone marrow hemopoiesis. Enterosorption exerted 
a positive influence on the structural-morphologic 
indexes and regenerative potential of kidneys and 
liver, mitigated manifestations of oxidative stress, 
decreased the level of EGI, promoted deliganding 
of albumin molecule and deloading of erythrocyte 
membranes.
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